Skip to main content
TipRanks
Go Ultimate75% OFF

TAKEDA PHARMACEUTICAL CO LTD Insider Profile

4 Followers

TAKEDA PHARMACEUTICAL CO LTD, Ten Percent Owner at Ovid Therapeutics, holds 8.78M shares in Ovid Therapeutics (Ticker: OVID), holds ― shares in Calithera Bio (Ticker: CALA), holds 0.00 shares in HilleVax, Inc (Ticker: HLVX).

TAKEDA PHARMACEUTICAL CO LTD's Trading History

OVID
Ovid Therapeutics
Dec 09, 2025Ten Percent OwnerUninformative Buy―$22.31M
HLVX
HilleVax, Inc
Sep 19, 2025―Uninformative Sell13.11M$0.00
PHAT
Phathom Pharmaceuticals
Jan 25, 2024Ten Percent OwnerInformative Sell30.00M$22.76M
DAWN
Day One Biopharmaceuticals
Dec 09, 2021―Informative Sell5.50M$131.77M
XLO
Xilio Therapeutics
Oct 26, 2021Ten Percent OwnerUninformative Buy―$11.91M
THRX
Theseus Pharmaceuticals
Oct 15, 2021―Uninformative Buy―$6.56M
CALA
Calithera Bio
――――

You May Also Like

TAKEDA PHARMACEUTICAL CO LTD insider profile FAQ

What is the percentage of profitable transactions made by TAKEDA PHARMACEUTICAL CO LTD?
The percentage of profitable transactions made by TAKEDA PHARMACEUTICAL CO LTD is 60%.
What is the average return per transaction made by TAKEDA PHARMACEUTICAL CO LTD?
The average return per transaction made by TAKEDA PHARMACEUTICAL CO LTD is 26.70%.
What stocks does TAKEDA PHARMACEUTICAL CO LTD hold?
TAKEDA PHARMACEUTICAL CO LTD holds: OVID, CALA, PHAT, DAWN, THRX, XLO, HLVX stocks.
What was TAKEDA PHARMACEUTICAL CO LTD's most profitable transaction?
TAKEDA PHARMACEUTICAL CO LTD’s most profitable transaction was an Informative Buy of OVID stock on November 22, 2019. The return on the trade was 119.20%.
What is TAKEDA PHARMACEUTICAL CO LTD's role in Ovid Therapeutics?
TAKEDA PHARMACEUTICAL CO LTD's role in Ovid Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.